Table 1 Association of Neu2 expression with clinicopathological characteristics in patients with pancreatic cancer
Gender | |||
Male | 12 | ||
Female | 8 | ||
Age | 40–85 | ||
Location of tumor | |||
Head, body | 20 | ||
T category | |||
T1 | 1 | ||
T2 | 11 | ||
T3 | 8 | ||
N category | |||
N0 | 11 | ||
N1 | 9 | ||
M category | |||
M0 | 20 | ||
M1 | 0 | ||
Surgical procedure | |||
Pancreatoduodenectomy | 20 | ||
Histological differentiation | |||
Well | 3 | ||
Moderately | 16 | ||
Poorly | 1 | ||
Chemotherapy | 0 | ||
Adjuvant therapy | 0 | ||
Neu2 expression | |||
Neu2 negative | 17 | ||
Neu2 positive | 3 | ||
